Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Insulet
PODD
$10.3B
| $10.3M | 0.01% |
67,714
+56,475
| +502% | +$9.41M |
|
1002
CALL
Coinbase
COIN
$49.2B
| $10.2M | 0.01% |
69,800
-9,100
| -12% | -$1.64M |
|
1003
Shell
SHEL
$257B
| $10.2M | 0.01% |
131,161
+127,637
| +3,622% | +$11M |
|
|
PRMB
1004
Primo Brands
PRMB
$8.37B
| $10.2M | 0.01% |
415,527
+388,599
| +1,443% | +$8.62M |
|
1005
Haemonetics
HAE
$4.95B
| $10.1M | 0.01% |
+134,981
| New | +$8.67M |
|
1006
CALL
Booking.com
BKNG
$158B
| $10M | 0.01% |
56,100
-23,900
| -30% | -$4.08M |
|
1007
iShares MSCI India ETF
INDA
$6.61B
| $10M | 0.01% |
+202,389
| New | +$9.87M |
|
1008
PUT
Honeywell
HON
$68.4B
| $9.99M | 0.01% |
44,600
+15,900
| +55% | +$3.55M |
|
1009
CALL
Delta Air Lines
DAL
$54.2B
| $9.97M | 0.01% |
106,400
-35,000
| -25% | -$2.64M |
|
1010
CALL
Commault Systems
CVLT
$5.55B
| $9.96M | 0.01% |
+70,300
| New | +$7.55M |
|
1011
National Health Investors
NHI
$3.6B
| $9.92M | 0.01% |
+130,123
| New | +$9.96M |
|
1012
SBA Communications
SBAC
$19.4B
| $9.86M | 0.01% |
55,892
+54,302
| +3,415% | +$11.2M |
|
1013
FIGS
FIGS
$2.44B
| $9.86M | 0.01% |
+963,651
| New | +$12.7M |
|
1014
CALL
Nexstar Media Group
NXST
$5.73B
| $9.82M | 0.01% |
55,000
| – | – |
|
1015
Acadia Pharmaceuticals
ACAD
$5.08B
| $9.82M | 0.01% |
388,024
+75,042
| +24% | +$1.65M |
|
|
SEI
1016
Solaris Energy Infrastructure
SEI
$3.51B
| $9.78M | 0.01% |
121,598
-165,573
| -58% | -$11.8M |
|
1017
Pagaya Technologies
PGY
$1.81B
| $9.78M | 0.01% |
535,780
+251,479
| +88% | +$3.57M |
|
1018
PUT
Cloudflare
NET
$104B
| $9.71M | 0.01% |
+39,600
| New | +$8.66M |
|
1019
CleanSpark
CLSK
$3.08B
| $9.69M | 0.01% |
+666,268
| New | +$9.4M |
|
1020
CALL
McDonald's
MCD
$192B
| $9.68M | 0.01% |
35,800
-24,600
| -41% | -$7.05M |
|
1021
Core & Main
CNM
$8.4B
| $9.64M | 0.01% |
199,699
-538,990
| -73% | -$26.6M |
|
1022
CALL
Capital One
COF
$134B
| $9.63M | 0.01% |
48,000
-84,000
| -64% | -$16.1M |
|
|
NUVL
1023
PUT
DELISTED
Nuvalent
NUVL
| $9.61M | 0.01% |
+77,800
| New | +$8.37M |
|
1024
CALL
Ocular Therapeutix
OCUL
$2.43B
| $9.58M | 0.01% |
+975,200
| New | +$8.84M |
|
1025
Jabil
JBL
$32.8B
| $9.53M | 0.01% |
24,729
-346,782
| -93% | -$120M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.